Dr. Tejaswi Venkata Mudigonda, MD

Dr. Mudigonda practices at Rads of America, LLC in Goodlettsville, Tennessee.

Dr. Mudigonda's NPI, 1891143277, was assigned on May 26, 2016. Dr. Mudigonda graduated from Vanderbilt University School of Medicine in 2016. Dr. Mudigonda holds Tennessee license 68967.

Dr. Mudigonda's primary practice is Rads of America, LLC, at 3024 Business Park Cir, Goodlettsville, TN 37072 in Davidson County. The practice phone is (615) 356-3999.

Dr. Mudigonda's primary practice is Rads of America, LLC in Goodlettsville, Tennessee. The medical group on file is Advanced Diagnostic Imaging. Dmand AI also links Dr. Mudigonda to 3 more medical groups, 2 group practices and clinics and 1 physician office, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Mudigonda practices, 3 sites in all. Vendor and product names are available with a free account.

Mohs-micrographic surgery is Dr. Mudigonda's primary specialty in the NPI Registry, under taxonomy code 207ND0101X. Dr. Mudigonda is licensed in Tennessee.

CMS data shows 213 Medicare services from Dr. Mudigonda across 9 procedure codes in 2024, for 125 Medicare patients. Medicare paid $58,275 for them. Every service was in an office.

CMS counts 125 Medicare patients who saw Dr. Mudigonda in 2024. The largest group is 65 to 74, with 58 patients. 65% of them have high blood pressure, and 58% have high cholesterol. 11% are also on Medicaid. Their average risk score is 0.98, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Mudigonda's median patient age at 66, with 46% women.

In 2024, Dr. Mudigonda wrote 144 Medicare Part D claims for 109 patients. 95% of them were for generic drugs. CMS names the drug for 110 of them, across 4 drugs with 11 or more claims each, at $1,002 in total drug cost. In 2023, CMS named 345 claims across 11 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 100 out of 100 for Dr. Mudigonda for performance year 2024, reported as part of a group. Dr. Mudigonda accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 133 procedures of melanoma (skin cancer) excision by Dr. Mudigonda, more than 95% of the clinicians it reports for that procedure.

Removal of nail tissue: 1 to 10 procedures (CMS shows small counts as a range)

Removal of tissue: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 13 papers to Dr. Mudigonda, published from 2011 to 2015. 2011 was the busiest year, with 2. The most frequent topics are Melanoma and Skin Neoplasms. Dr. Mudigonda has published most often in Dermatol Surg. Dr. Mudigonda's most frequent co-authors are Tushar S. Dabade, MD, Jeffrey A. Sosman, MD and Igor Puzanov, MD.

CMS Open Payments shows 140 general payments to Dr. Mudigonda from 20 drug and device companies from 2017 to 2025. Food and beverage make up the largest share, 94% of the total. Abbvie Inc. paid the most, $2,063.

Dr. Mudigonda graduated from Vanderbilt University School of Medicine in 2016.